

JAMA Network
The JAMA Network
Audio Interviews with Authors of articles in the JAMA Network Specialty Journals
Episodes
Mentioned books
Sep 17, 2025 • 22min
JAMA Dermatology : Nicotinamide for Skin Cancer Chemoprevention
Interview with Lee Wheless, MD, PhD, author of Nicotinamide for Skin Cancer Chemoprevention. Hosted by Adewole S. Adamson, MD. Related Content: Nicotinamide for Skin Cancer Chemoprevention (Original Investigation) Nicotinamide for Skin Cancer Chemoprevention (Editorial)
Sep 16, 2025 • 38min
JAMA Cardiology : From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more
Join Gregory Curfman, JAMA Executive Editor, and Robert O. Bonow, JAMA Cardiology Editor, as they delve into groundbreaking research from the European Society of Cardiology Congress. They discuss the rise of remote monitoring for detecting asymptomatic atrial fibrillation, the benefits of semaglutide and tirzepatide for heart failure, and findings that show improved outcomes from complete revascularization in myocardial infarction. They also highlight important vaccination insights and the ongoing challenges of women’s participation in cardiovascular research.
Sep 10, 2025 • 22min
JAMA Dermatology : A Risk Prediction Tool for Invasive Melanoma
Interview with David C. Whiteman, MBBS, PhD, author of A Risk Prediction Tool for Invasive Melanoma. Hosted by Adewole S. Adamson, MD. Related Content: A Risk Prediction Tool for Invasive Melanoma
Sep 10, 2025 • 18min
JAMA Cardiology : Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
Interview with Frederick L. Ruberg, MD, and Mathew S. Maurer, MD, authors of Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. Hosted by Sadiya Khan, MD. Related Content: Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
Sep 2, 2025 • 12min
JAMA Internal Medicine : Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
Azelastine nasal spray shows promise as a preventive treatment for COVID-19, according to a study involving nearly 600 participants. The experts discuss its significant reductions in infection rates and potential benefits against other respiratory viruses. A phase two study points to its efficacy as an antiviral treatment, though the need for larger trials is emphasized. The episode highlights its mechanisms and implications for at-risk populations, underscoring a hopeful advance in public health measures.
9 snips
Aug 27, 2025 • 13min
JAMA Surgery : Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US
In this engaging discussion, G. Caleb Alexander, MD, MS, from Johns Hopkins Bloomberg School of Public Health, and Hemalkumar B. Mehta, MS, PhD, dive into the burgeoning use of glucagon-like peptide-1 (GLP-1) agonists among bariatric surgery patients. They reveal that 14% of these patients initiate GLP-1 therapy due to insufficient weight loss, highlighting prescription trends and the evolving guidelines in this field. The conversation also emphasizes the vital need for better communication between patients and physicians about weight management post-surgery.
Aug 27, 2025 • 21min
JAMA Cardiology : Clinical Outcomes With Personalized Accelerated Physiologic Pacing in HFpEF
Interview with Margaret Infeld, MD, MS, author of Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction: Follow-Up of the myPACE Trial. Hosted by Robert Bonow, MD. Related Content: Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction
11 snips
Aug 25, 2025 • 17min
JAMA Internal Medicine : Nonhormonal Treatment of Menopausal Vasomotor Symptoms
In this enlightening discussion, Alison J. Huang, a prominent professor at UCSF, and Stephanie Faubion, a leading expert at the Mayo Clinic, tackle the complexities of managing menopausal vasomotor symptoms like hot flashes and night sweats. They delve into FDA-approved non-hormonal medications and evaluate their effectiveness compared to traditional options. The conversation highlights the significant challenges women face, including insurance hurdles and the need for better healthcare provider training. Misinformation and the importance of evidence-based treatments are also key topics, emphasizing the need for informed patient-provider conversations.
10 snips
Aug 20, 2025 • 24min
JAMA Psychiatry : Collaborative Care for Opioid Use Disorder in Primary Care
Anna D. Ratzliff and Andrew J. Saxon, both experts from the University of Washington School of Medicine, discuss innovative collaborative care models for treating opioid use disorder. They address the alarming rise in opioid-related fatalities and the need for better healthcare access. The duo highlights their study, showcasing how structured collaborative care improves treatment outcomes and mental health quality of life. They also delve into the creation of a specialized registry aimed at optimizing care integration within existing primary care systems.
Aug 18, 2025 • 13min
JAMA Internal Medicine : The JAMA Internal Medicine Editorial Fellowship Experience
Three editorial fellows share their transformative experiences at a leading internal medicine journal. They delve into the challenges and rewards of the fellowship, highlighting personal growth and teamwork. The impact on their writing and understanding of scientific literature is profound, showcasing the importance of clear communication in medical contexts. They also reflect on honing research skills and the value of strong editorial processes. Friendships formed during the fellowship contribute to a richer understanding of the medical field.


